Morphological Features of Metastatic Gastrointestinal Stromal Tumors after Gleevec Treatment - Two Cases Report -
ÃÖÁØÇõ, ¹è¿µ°æ, ¼Û¼±±³, ±èÈ«Áø, ½É¹Îö, ÀÌ°æÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÁØÇõ ( Choi Joon-Hyuk )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹è¿µ°æ ( Bae Young-Kyung )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼Û¼±±³ ( Song Sun-Kyo )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÈ«Áø ( Kim Hong-Jin )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
½É¹Îö ( Shim Min-Chul )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÀÌ°æÈñ ( Lee Kyoung-Hee )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
KMID : 0357920090430040368
Abstract
We report two patients with metastatic gastrointestinal stromal tumors (GISTs) with a focus on the morphological features related to Gleevec treatment. In case 1, a 50-year-old woman presented with a 1.8 cm metastatic GIST in the liver after resection of a gastric GIST. Majority of the metastatic tumor showed fibrosis and hyalinization after 8 weeks of Gleevec treatment. CD117-positive cells were present in approximately 1% of the overall tumor. In case 2, a 2 cm and 14 cm metastatic liver masses were found in a 54-year-old man who had a rectal GIST. After 4 weeks of Gleevec treatment, metastatic tumors showed a decrease in size on CT scan. The metastatic tumors showed a decrease in number of tumor cells. The hemorrhage, cystic changes, necrosis, and fibrosis made up approximately 90% of the tumor. The morphological features related to Gleevec treatment are important for correct diagnosis and evaluation of tumor response and prognosis.
Å°¿öµå
Gastrointestinal stromal tumor;Gleevec;Liver;Metastasis;Morphology
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸